This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $1200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Yen-Chih Wang, PhD
Assistant Director, Analytical Development and Quality Control at Ionis Pharmaceuticals
Speaker

Profile

Dr. Yen-Chih Wang obtained his Ph.D. degree in chemistry from University of Minnesota. His research focused on peptide chemistry and combinatorial chemistry. His career about peptides resumed and expanded to oligonucleotide synthesis when he was a senior scientist in Quantum-Si. Yen-Chih got familiarized with instrumental analysis techniques and industrial standards when he was a Sr. analytical chemist in Avomeen (now part of Element). Yen-Chih Wang is currently Assistant Director, Analytical Development and Quality Control at Ionis Pharmaceuticals, Inc., Carlsbad, California. His role is to develop analytical methods for oligonucleotide therapeutics and measure physical properties of oligonucleotides.

Agenda Sessions

  • QC Method Development & Duplex Stability Analysis of siRNAs

    9:30am